Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HealthCare Global EnterprisesNSE:HCG +1.47%83 ROC (Joel Greenblatt) % is 8.54% as of Mar. 2026, which is 4% below its 10-year median of 8.93. GuruFocus rates NSE:HCG with a GF Score™ of 83/100 and a GF Value™ of ₹581.51 (Modestly Overvalued). The stock has 2 warning signs investors should review. Among 666 Healthcare Providers & Services companies, HealthCare Global Enterprises ranks worse than 54.2% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. HealthCare Global Enterprises's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 8.54%.
The historical rank and industry rank for HealthCare Global Enterprises's ROC (Joel Greenblatt) % or its related term are showing as below:
NSE:HCG'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -8.32 Med: 8.93 Max: 13.16
Current: 10.01
During the past 12 years, HealthCare Global Enterprises's highest ROC (Joel Greenblatt) % was 13.16%. The lowest was -8.32%. And the median was 8.93%.
NSE:HCG's ROC (Joel Greenblatt) % is ranked worse than 54.2% of 666
companies
in the Healthcare Providers & Services industry
Industry Median: 12.47
vs NSE:HCG: 10.01
HealthCare Global Enterprises (NSE:HCG) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HealthCare Global Enterprises ROC (Joel Greenblatt) % Chart
NSE:HCG vs HCA, THC, DVA: ROC (Joel Greenblatt) % Comparison
For the Medical Care Facilities subindustry, HealthCare Global Enterprises's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HealthCare Global Enterprises ROC (Joel Greenblatt) % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, HealthCare Global Enterprises's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where HealthCare Global Enterprises's ROC (Joel Greenblatt) % falls into.
HealthCare Global Enterprises ROC (Joel Greenblatt) % Calculation
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 8.54% mean?
HealthCare Global Enterprises (NSE:HCG) has a ROC (Joel Greenblatt) % of 8.54% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on HealthCare Global Enterprises and its competitors. This is near median its historical median of 8.93. According to the industry distribution chart, HealthCare Global Enterprises ranks #361 out of 666 companies in the Healthcare Providers & Services industry, placing it in the top 54.2%.
Is HealthCare Global Enterprises' ROC (Joel Greenblatt) % too high?
HealthCare Global Enterprises' current ROC (Joel Greenblatt) % of 8.54% is near median its 10-year median of 8.93. The Healthcare Providers & Services industry median ROC (Joel Greenblatt) % is 12.47. HealthCare Global Enterprises' value of 8.54% is 31.5% below this industry median. Based on the distribution chart, HealthCare Global Enterprises ranks #361 out of 666 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, HealthCare Global Enterprises has a GF Score™ of 83/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does HealthCare Global Enterprises' ROC (Joel Greenblatt) % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, HealthCare Global Enterprises ranks #361 out of 666 companies for ROC (Joel Greenblatt) %. This places HealthCare Global Enterprises in the lower half of its industry. The industry median ROC (Joel Greenblatt) % is 12.47. HealthCare Global Enterprises' value of 8.54% is 31.5% below this benchmark. While the company's 10-year median is 8.93 vs. the industry median of 12.47, HealthCare Global Enterprises has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Healthcare Providers & Services company?
The median ROC (Joel Greenblatt) % among Healthcare Providers & Services companies is 12.47, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. HealthCare Global Enterprises's current ROC (Joel Greenblatt) % of 8.54% is 31.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on HealthCare Global Enterprises and its competitors. For the Healthcare Providers & Services industry, the median ROC (Joel Greenblatt) % is 12.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HealthCare Global Enterprises's current ROC (Joel Greenblatt) % is 8.54%, which is near median its own 10-year median of 8.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HealthCare Global Enterprises stock overvalued right now?
Based on GuruFocus' analysis, HealthCare Global Enterprises (NSE:HCG) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹581.51, compared to a current price of ₹670.95 — trading 15.4% above its estimated fair value. The current ROC (Joel Greenblatt) % is 8.54%, which is near median its 10-year median of 8.93 and 31.5% below the Healthcare Providers & Services industry median of 12.47. HealthCare Global Enterprises' overall GF Score™ is 83/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For HealthCare Global Enterprises (NSE:HCG), the current ROC (Joel Greenblatt) % is 8.54% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is HealthCare Global Enterprises (NSE:HCG) Overvalued in 2026?
Based on GuruFocus' analysis, HealthCare Global Enterprises stock appears to be overvalued.
The current stock price of ₹670.95 is trading 15.4% above its estimated GF Value™ of ₹581.51.
GuruFocus considers HealthCare Global Enterprises to be Modestly Overvalued.
Key valuation signals for NSE:HCG:
ROC (Joel Greenblatt) %: 8.54% (near median its 10-year median of 8.93)
GF Value™: ₹581.51 vs. price of ₹670.95 (15.4% above fair value)
Industry Position: 31.5% below the Healthcare Providers & Services median (#361 of 666)
No single metric tells the full story. See the NSE:HCG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
HealthCare Global Enterprises Business Description
HealthCare Global Enterprises Ltd operates in oncology, providing comprehensive cancer diagnosis and treatment services including medical oncology, radiation therapy, and surgical oncology. It also offers fertility treatment services under the Milann brand, along with multi-specialty hospital care in key medical disciplines. The company's operations span many metropolitan and non-metro cities across India and extend internationally with cancer care centers in Africa. HCG generates revenue through patient services in oncology, fertility treatments, diagnostics, and multi-specialty hospital care, leveraging technology and a networked business model to deliver patient-centric healthcare.
83GF Score
Get the complete analysis for NSE:HCG
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:HCG has been successfully added to your 
